Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
ESOCDAWN: Thrombectomy Effective Up to 24 Hours After StrokeThe DAWN trial showed impressive results in selected stroke patients presenting late and should substantially expand the population eligible for endovascular treatment.
SOCRATES: Ticagrelor Not Superior to Aspirin for Stroke, TIA The new antiplatelet just missed the primary endpoint of stroke, MI, and death at 90 days in this 13,000-patient trial, but
results suggest it may be better given in combination with -- rather than instead of -- aspirin.